Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $114.45 USD
Change Today +0.01 / 0.01%
Volume 4.6M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Perry A. Karsen

Chief Executive Officer of Celgene Cellular Therapeutics, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 47 board members in 5 different organizations across 10 different industries.

See Board Relationships
59$7,259,162
As of Fiscal Year 2014

Background*

Mr. Perry A. Karsen serves as the President of Stalar 4, Inc. and Stalar 3 Inc. Mr. Karsen serves as an Executive Officer of Healthcare IT, Inc. He serves as Chief Executive Officer of Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation. Mr. Karsen served as the Chief Operations Officer of Celgene Corporation since July 2010 until August 1, 2014, and its Executive Vice President since February 15, 2012 until August 1, 2014. He served as the ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: --

Board Members Memberships*

Former Director
Former Director
Former Director
President and Director
President and Director
2011-Present
Director
2013-Present
Director
2014-Present
Director, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee

Education*

Master's Degree
Duke University
BS
University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$666,500
Total Annual Compensation$666,500

Stock Options*

Restricted Stock Awards$368,088
All Other Compensation$24,440
Exercised Options125,192
Exercised Options Value$8,114,178
Exercisable Options68,368
Unexercisable Options201,153
Total Value of Options$8,114,178
Total Number of Options394,713

Total Compensation*

Total Annual Cash Compensation$4,813,454
Total Short Term Compensation$666,500
Other Long Term Compensation$392,528
Total Calculated Compensation$7,259,162
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $114.45 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.